165 related articles for article (PubMed ID: 23039852)
21. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets.
Crist SA; Elzey BD; Ludwig AT; Griffith TS; Staack JB; Lentz SR; Ratliff TL
Exp Hematol; 2004 Nov; 32(11):1073-81. PubMed ID: 15539085
[TBL] [Abstract][Full Text] [Related]
22. Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.
Hashizume S; Akaike M; Azuma H; Ishikawa K; Yoshida S; Sumitomo-Ueda Y; Yagi S; Ikeda Y; Iwase T; Aihara K; Abe M; Sata M; Matsumoto T
J Atheroscler Thromb; 2011; 18(2):138-47. PubMed ID: 21060209
[TBL] [Abstract][Full Text] [Related]
23. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV.
Rozmyslowicz T; Majka M; Kijowski J; Murphy SL; Conover DO; Poncz M; Ratajczak J; Gaulton GN; Ratajczak MZ
AIDS; 2003 Jan; 17(1):33-42. PubMed ID: 12478067
[TBL] [Abstract][Full Text] [Related]
24. Expression of the collagen receptor glycoprotein VI during megakaryocyte differentiation.
Berlanga O; Bobe R; Becker M; Murphy G; Leduc M; Bon C; Barry FA; Gibbins JM; Garcia P; Frampton J; Watson SP
Blood; 2000 Oct; 96(8):2740-5. PubMed ID: 11023507
[TBL] [Abstract][Full Text] [Related]
25. PPARγ agonists negatively regulate αIIbβ3 integrin outside-in signaling and platelet function through up-regulation of protein kinase A activity.
Unsworth AJ; Kriek N; Bye AP; Naran K; Sage T; Flora GD; Gibbins JM
J Thromb Haemost; 2017 Feb; 15(2):356-369. PubMed ID: 27896950
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S; Sidell N; Fisher PB; Roman J
Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
[TBL] [Abstract][Full Text] [Related]
27. The serum- and glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signaling and function by regulation of Orai1 expression in megakaryocytes.
Borst O; Schmidt EM; Münzer P; Schönberger T; Towhid ST; Elvers M; Leibrock C; Schmid E; Eylenstein A; Kuhl D; May AE; Gawaz M; Lang F
Blood; 2012 Jan; 119(1):251-61. PubMed ID: 22031864
[TBL] [Abstract][Full Text] [Related]
28. Silencing of a targeted protein in in vivo platelets using a lentiviral vector delivering short hairpin RNA sequence.
Ohmori T; Kashiwakura Y; Ishiwata A; Madoiwa S; Mimuro J; Sakata Y
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2266-72. PubMed ID: 17872456
[TBL] [Abstract][Full Text] [Related]
29. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.
Yousefi B; Azimi A; Majidinia M; Shafiei-Irannejad V; Badalzadeh R; Baradaran B; Zarghami N; Samadi N
Tumour Biol; 2017 Oct; 39(10):1010428317716501. PubMed ID: 28978268
[TBL] [Abstract][Full Text] [Related]
30. Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and the megakaryoblastic cell line CHRF-288.
Konkle BA; Schick PK; He X; Liu RJ; Mazur EM
Arterioscler Thromb; 1993 May; 13(5):669-74. PubMed ID: 8485117
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor-γ interrupts angiogenic signal transduction by transrepression of platelet-derived growth factor-β receptor in hepatic stellate cells.
Zhang F; Kong D; Chen L; Zhang X; Lian N; Zhu X; Lu Y; Zheng S
J Cell Sci; 2014 Jan; 127(Pt 2):305-14. PubMed ID: 24259663
[TBL] [Abstract][Full Text] [Related]
32. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta.
Ali FY; Davidson SJ; Moraes LA; Traves SL; Paul-Clark M; Bishop-Bailey D; Warner TD; Mitchell JA
FASEB J; 2006 Feb; 20(2):326-8. PubMed ID: 16368717
[TBL] [Abstract][Full Text] [Related]
33. Expression and function of the collagen receptor GPVI during megakaryocyte maturation.
Lagrue-Lak-Hal AH; Debili N; Kingbury G; Lecut C; Le Couedic JP; Villeval JL; Jandrot-Perrus M; Vainchenker W
J Biol Chem; 2001 May; 276(18):15316-25. PubMed ID: 11278467
[TBL] [Abstract][Full Text] [Related]
34. Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.
Schopfer FJ; Cole MP; Groeger AL; Chen CS; Khoo NK; Woodcock SR; Golin-Bisello F; Motanya UN; Li Y; Zhang J; Garcia-Barrio MT; Rudolph TK; Rudolph V; Bonacci G; Baker PR; Xu HE; Batthyany CI; Chen YE; Hallis TM; Freeman BA
J Biol Chem; 2010 Apr; 285(16):12321-33. PubMed ID: 20097754
[TBL] [Abstract][Full Text] [Related]
35. Identification of Gz alpha as a pertussis toxin-insensitive G protein in human platelets and megakaryocytes.
Gagnon AW; Manning DR; Catani L; Gewirtz A; Poncz M; Brass LF
Blood; 1991 Sep; 78(5):1247-53. PubMed ID: 1908722
[TBL] [Abstract][Full Text] [Related]
36. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms.
Nagy ZS; Czimmerer Z; Szanto A; Nagy L
Immunobiology; 2013 Nov; 218(11):1336-44. PubMed ID: 23870825
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
[TBL] [Abstract][Full Text] [Related]
38. Human platelets and megakaryocytes contain alternately spliced glycoprotein IIb mRNAs.
Bray PF; Leung CS; Shuman MA
J Biol Chem; 1990 Jun; 265(17):9587-90. PubMed ID: 2351656
[TBL] [Abstract][Full Text] [Related]
39. The Peroxisome Proliferator-Activated Receptor (PPAR)-
Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
[TBL] [Abstract][Full Text] [Related]
40. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins.
Tesse A; Al-Massarani G; Wangensteen R; Reitenbach S; Martínez MC; Andriantsitohaina R
J Pharmacol Exp Ther; 2008 Feb; 324(2):539-47. PubMed ID: 18039959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
